Key result
The ABCDMP score demonstrated poor discriminatory ability for predicting inpatient mortality in patients with AECOPD and cardiovascular diseases, yielding an AUROC of 0.556.
Why the study?
The ABCDMP clinical risk score was validated in China for risk stratification in COPD, but had not been tested internationally in AECOPD patients with concurrent cardiovascular diseases.
Does the ABCDMP score accurately predict inpatient mortality, 30-day mortality, and 90-day readmission in patients hospitalized with AECOPD and cardiovascular comorbidities?
Observational (n=512)
Yes
Does the ABCDMP score accurately predict inpatient mortality, 30-day mortality, and 90-day readmission in patients hospitalized with AECOPD and cardiovascular comorbidities?
The ABCDMP score demonstrated limited discriminatory performance for predicting mortality and readmission in UAE patients with AECOPD and cardiovascular comorbidities, suggesting it may not be generalizable outside its derivation population without refinement.
May not guide risk stratification in AECOPD with CVD; leaves open need for population-specific validation or refinement.
Chronic Obstructive Pulmonary Disease (COPD) stands as a leading cause of death globally, with AECOPD significantly worsening patient outcomes. The intersection of COPD with CVDs further escalates the risk, highlighting the need for precise prognostic tools. The ABCDMP score, previously validated in China, offers a simple clinical approach to risk stratification but has not been tested internationally. This study explores the efficacy of the ABCDMP score in predicting disease severity and mortality among AECOPD patients with concurrent CVDs in the UAE. This multicenter retrospective study was conducted in 18 hospitals across the UAE and assessed the predictive accuracy of the ABCDMP score for inpatient mortality, 30-day mortality, and 90-day readmission among AECOPD patients with CVDs. The study included 512 participants, of whom 343 (67.0%) were female, 391 (76.4%) were aged 65 years or older, and 89 (17.4%) had a hospital stay of more than 30 days. The ABCDMP score was evaluated using the Area Under the Receiver Operating Characteristic (AUROC). The ABCDMP score curves for inpatient death, 30-day death, and 90-day readmission were 0.55 (95% CI: 0.49-0.61), 0.48 (95% CI: 0.40-0.55), and 0.58 (95% CI: 0.52-63), respectively. Significant differences in mortality rates were observed among patients with different lengths of stay ( P = .012) and in abilities to wash independently ( P = .001), dress ( P = .001), and feed ( P = .001). Moreover, the analysis revealed significant differences in the occurrence of patient deaths across various comorbidities, notably renal diseases ( P = .003) and atrial fibrillation ( P = .001). The ABCDMP score’s effectiveness in predicting mortality and readmission rates among AECOPD patients with cardiovascular conditions was found to be limited, indicating the need for its enhancement or the development of more accurate tools.
No takes yet. Share an insight, caveat, or question.
khadeijah Almarshoodi (2026) conducted an observational in Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and cardiovascular diseases (CVDs) (n=512). ABCDMP score was evaluated on Inpatient mortality prediction (AUROC) (AUROC 0.556, 95% CI 0.495-0.616). The ABCDMP score demonstrated poor discriminatory ability for predicting inpatient mortality in patients with AECOPD and cardiovascular diseases, yielding an AUROC of 0.556.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: